<- Go Home
Zoetis Inc.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally.
Market Cap
$74.8B
Volume
2.4M
Cash and Equivalents
$1.7B
EBITDA
$3.8B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.4B
Profit Margin
70.09%
52 Week High
$200.53
52 Week Low
$144.80
Dividend
1.21%
Price / Book Value
14.31
Price / Earnings
31.20
Price / Tangible Book Value
57.45
Enterprise Value
$79.9B
Enterprise Value / EBITDA
20.70
Operating Income
$3.3B
Return on Equity
47.30%
Return on Assets
14.66
Cash and Short Term Investments
$1.7B
Debt
$6.8B
Equity
$5.2B
Revenue
$9.2B
Unlevered FCF
$2.0B
Sector
Pharmaceuticals
Category
N/A
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick Premium